Granule cell disinhibition in dentate gyrus of genetically seizure susceptible El mice.
Paired-pulse inhibition was investigated electrophysiologically in the dentate gyrus using hippocampal slices from epileptic El mice. At short interpulse intervals (IPIs), the inhibition was 30% in the El, and 90% in the control ddY mice at the ages of 10 and 15 weeks. No difference in inhibition was observed at the age of 5 weeks. Bicuculline, a GABAA receptor antagonists, attenuated the inhibition during short IPIs n the ddY mice, while in the El mice, phenobarbital and flunitrazepam, which enhance GABAA receptor function, restored the inhibitory activity comparable to that of the ddY. The disinhibition progressed with growth, closely correlating with seizure development in El mice. These results suggest that decrease in the GABAergic inhibition occurs in the dentate gyrus of the El mice with growth. GABA concentration in the hippocampus was also quantified using HPLC. In El mice, GABA level was significantly lower than that in ddY mice at the ages of 5 and 15 weeks. Thus, the disinhibition observed in the El dentate gyrus at 15 weeks of age does not appear to be directly related to the content of GABA. GABAergic disinhibition suggests possible loss of unknown inhibition control factor(s) in the El dentate gyrus as growth progresses. The growth-dependent disinhibition in the granule cells may be prerequisite for epileptogenesis in El mice.
Ono
T
T
Department of Molecular Biology, School of Medicine, University of Occupational and Environmental Health, kitakyushu, Japan.
Fueta
Y
Y
Janjua
N A
NA
Ohmori
O
O
Ohno
K
K
Murai
Y
Y
Mita
T
T
D000375:Aging / Q000378:metabolism; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001640:Bicuculline / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D018891:Dentate Gyrus / Q000378:metabolism / Q000473:pathology*; D004594:Electrophysiology; D005445:Flunitrazepam / Q000494:pharmacology; D018756:GABA Antagonists / Q000494:pharmacology; D018757:GABA Modulators / Q000494:pharmacology; D018698:Glutamic Acid / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010634:Phenobarbital / Q000494:pharmacology; D012640:Seizures / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism / Q000502:physiology
D000927:Anticonvulsants; D018756:GABA Antagonists; D018757:GABA Modulators; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D005445:Flunitrazepam; D001640:Bicuculline; D010634:Phenobarbital